1. Home
  2. MIDD vs BLTE Comparison

MIDD vs BLTE Comparison

Compare MIDD & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Middleby Corporation (The)

MIDD

Middleby Corporation (The)

HOLD

Current Price

$141.69

Market Cap

6.5B

Sector

Industrials

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$159.60

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIDD
BLTE
Founded
1888
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
6.6B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
MIDD
BLTE
Price
$141.69
$159.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
7
Target Price
$180.13
$198.00
AVG Volume (30 Days)
503.8K
128.2K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,201,202,000.00
N/A
Revenue This Year
$5.87
N/A
Revenue Next Year
$3.22
$492.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$110.82
$56.68
52 Week High
$169.44
$200.00

Technical Indicators

Market Signals
Indicator
MIDD
BLTE
Relative Strength Index (RSI) 48.85 43.71
Support Level $138.51 $157.63
Resistance Level $145.77 $161.28
Average True Range (ATR) 4.39 7.12
MACD 0.60 -0.78
Stochastic Oscillator 46.11 19.71

Price Performance

Historical Comparison
MIDD
BLTE

About MIDD Middleby Corporation (The)

The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: